Ponzi Schemes 101: How You Can Avoid Being a Victim
Grocery Chain Pays Big Fine for Selling Recalled Products
All Bets Are On for Britain's Next Royal Baby Name
Market Wrap: Dow Sets Record as Fed Says Rates Will Stay Low
Johnson & Johnson Launches Offer for Crucell
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Still in hot water over its "phantom recall" of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Novavax (NVAX) shares soared some 10 percent today after the small clinical-stage biotechnology company announced positive preclinical results for...